NCT02133196
- Conditions
- Adenocarcinoma, Adenosquamous Carcinoma, Advanced NSCLC, +23 more
- Locations
-
- National Institutes of Health Clinical Center Bethesda, Maryland, United States
Clinical trial condition
Advanced NSCLC
Explore clinical trials studying Advanced NSCLC. Study availability and eligibility vary by location and protocol.
15 public trials
7 recruiting studies
Advanced NSCLC trial results
NCT06924606
- Conditions
- Advanced NSCLC
- Locations
-
- Beijing Chest Hospital, Capital Medical University Beijing, Beijing Municipality, China
- Jilin Cancer Hospital Jilin City, Changchun, China
- Hunan Cancer Hospital Hunan, Changsha, China
- West China Hospital, Sichuan University Sichuan, Chengdu, China
NCT06758557
- Conditions
- Advanced Endometrial Cancer, Advanced NSCLC, Endometrial Neoplasms, +11 more
- Locations
-
- Affiliated Hospital of Hebei University / School of Clinical Medicine Baoding, Hebei, China
- Harbin Medical University Cancer Hospital Harbin, Heilongjiang, China
- The First Affiliated Hospital of Henan University of Science & Technology Luoyang, Henan, China
- Henan Cancer Hospital Zhengzhou, Henan, China
NCT06752057
- Conditions
- Advanced NSCLC
- Locations
-
- First Affiliated Hospital of Nanchang University Nanchang, Jiangxi, China
- The First Hospital of Nanchang Nanchang, Jiangxi, China
NCT06751849
- Conditions
- Advanced NSCLC
- Locations
-
- First Affiliated Hospital of Nanchang University Nanchang, Jiangxi, China
- The First Hospital of Nanchang Nanchang, Jiangxi, China
NCT06751901
- Conditions
- Advanced NSCLC
- Locations
-
- First Affiliated Hospital of Nanchang University Nanchang, Jiangxi, China
- The First Hospital of Nanchang Nanchang, Jiangxi, China
NCT06752044
- Conditions
- Advanced NSCLC
- Locations
-
- First Affiliated Hospital of Nanchang University Nanchang, Jiangxi, China
- The First Hospital of Nanchang Nanchang, Jiangxi, China
Not Yet Recruiting
A Study of Combining Cabozantinib and Atezolizumab for Advanced/Metastatic NSCLC (Cabatezo-1)
NCT05859217
- Conditions
- Advanced NSCLC, Bronchial Neoplasms, Carcinoma, Bronchogenic, +11 more
- Locations
-
- The University of Kansas Cancer Center - Westwood Kansas City, Kansas, United States
- The University of Kansas Cancer Center - Indian Creek Overland Park, Kansas, United States
- The University of Kansas Cancer Center - North Kansas City, Missouri, United States
- The University of Kansas Cancer Center - Lee's Summit Lee's Summit, Missouri, United States
Not Yet Recruiting
A Single-arm Pilot Study of Tislelizumab Combined With Anlotinib in Patients With Advanced NSCLC With Driver-negative After Progression to Immunotherapy
NCT06356675
- Conditions
- Advanced NSCLC
- Locations
-
Not specified
NCT05219162
- Conditions
- Advanced NSCLC, Bronchial Neoplasms, Carcinoma, Bronchogenic, +8 more
- Locations
-
- Research Site Beijing, China
- Research Site Changsha, China
- Research Site Chengdu, China
- Research Site Dalian, China